Steroids for COVID-19: hidden hepatitis b danger revealed?
NCT ID NCT07154212
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at whether COVID-19 patients treated with steroids might have a reactivation of hepatitis B virus (HBV). Researchers followed 1,793 hospitalized adults who needed oxygen and received steroids for COVID-19 pneumonia. The goal was to see how well doctors followed HBV screening guidelines and how often the virus reactivated in patients who had past HBV infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Ljubljana
Ljubljana, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breath test could replace needles for checking pulse oximeters
- Can a new sedative combo make Children's gastroscopy safer?
- Can a simple inhaled combo keep pneumonia patients off ventilators?
- A soft buzz and a dim light could prevent Post-Surgery breathing trouble
- A simple switch in oxygen delivery may prevent dangerous drops in oxygen during routine procedures
- Can a simple roadside test catch liver disease before it turns deadly?